Ovarian Cancer: Ovarian cancer is a challenging disease with high mortality rates. Our research focuses on developing personalized treatment options for ovarian cancer patients, leveraging advancements in multiomics data analysis and targeted therapies. By understanding the unique molecular characteristics of each patient's tumor, we aim to improve treatment outcomes and enhance the quality of life for individuals battling ovarian cancer. See Shirley’s case.
Desmoid Cancer: Desmoid tumors are rare and locally aggressive neoplasms that can cause significant morbidity. Our research aims to unravel the underlying mechanisms of desmoid tumor development and progression, utilizing multiomics data to identify potential therapeutic targets. Through collaborative efforts with clinicians and researchers, we strive to develop innovative treatment strategies that can effectively manage desmoid cancer and improve patient outcomes. See Vanessa's Case.
Pancreatic Neuroendocrine Cancer: Pancreatic neuroendocrine cancer is a complex malignancy that poses diagnostic and therapeutic challenges. Our research focuses on elucidating the molecular and genetic characteristics of pancreatic neuroendocrine tumors, aiming to identify biomarkers and develop personalized treatment approaches. By leveraging multiomics data and precision medicine, we aim to improve the prognosis and survival rates of patients with this aggressive form of cancer. Apply to Join Steve's Case.
Small Cell Lung Cancer: Small cell lung cancer is an aggressive and rapidly progressing malignancy with limited treatment options. Our research endeavors to uncover novel therapeutic targets through comprehensive analysis of multiomics data, including genomic, transcriptomic, and proteomic information. By integrating these data sets and collaborating with experts across disciplines, we aim to develop targeted therapies and personalized treatment strategies to combat small cell lung cancer. Apply to Join This Case.